M Forrester
Overview
Explore the profile of M Forrester including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rowe R, Draper E, Kenyon S, Bevan C, Dickens J, Forrester M, et al.
BJOG
. 2020 May;
127(13):1665-1675.
PMID: 32437088
Objective: To review quality of care in births planned in midwifery-led settings, resulting in an intrapartum-related perinatal death. Design: Confidential enquiry. Setting: England, Scotland and Wales. Sample: Intrapartum stillbirths and...
2.
Chauhan A, Lalor T, Watson S, Adams D, Farrah T, Anand A, et al.
QJM
. 2019 Jun;
111(12):920-924.
PMID: 31222346
No abstract available.
3.
Trimarchi H, Paulero M, Rengel T, Gonzalez-Hoyos I, Forrester M, Lombi F, et al.
Case Rep Nephrol
. 2018 Aug;
2018:9514917.
PMID: 30155326
Glomerular diseases are one of the most frequent causes of chronic kidney disease, focal and segmental glomerulosclerosis being one of the commonest glomerulopathies. However, the etiology of this glomerular entity,...
4.
Trimarchi H, Paulero M, Canzonieri R, Schiel A, Iotti A, Costales-Collaguazo C, et al.
Case Rep Nephrol
. 2017 May;
2017:1292531.
PMID: 28473934
IgA nephropathy is the most frequent cause of primary glomerulonephritis, portends erratic patterns of clinical presentation, and lacks specific treatment. In general, it slowly progresses to end-stage renal disease. The...
5.
Trimarchi H, Canzonieri R, Schiel A, Costales-Collaguazo C, Politei J, Stern A, et al.
J Transl Med
. 2016 Oct;
14(1):289.
PMID: 27733175
Background: Certain glomerulopathies are associated with increased levels of CD80 (B7-1). We measured the urinary excretion of CD80, podocyturia and proteinuria in controls and in subjects with Fabry disease either...
6.
Trimarchi H, Canzonieri R, Muryan A, Schiel A, Araoz A, Paulero M, et al.
Case Rep Nephrol
. 2016 Mar;
2016:1492743.
PMID: 26942026
No specific or efficient treatment exists for Alport syndrome, an X-linked hereditary disease caused by mutations in collagen type IV, a crucial component of the glomerular basement membrane. Kidney failure...
7.
Trimarchi H, Canzonieri R, Muryan A, Schiel A, Araoz A, Forrester M, et al.
Case Rep Nephrol
. 2015 Jun;
2015:257628.
PMID: 26064721
The time for starting a patient with Fabry disease on enzyme replacement therapy is still a matter of debate, particularly when no overt classical clinical signs or symptoms are present....
8.
Trimarchi H, Forrester M, Lombi F, Pomeranz V, Rana M, Karl A, et al.
Case Rep Nephrol
. 2014 Jun;
2014:854521.
PMID: 24959362
Patients with Fabry disease present a higher risk of cardiovascular and kidney morbidity. We present a patient with a past history of biopsy-proven Fabry disease and stage 3 chronic kidney...
9.
Trimarchi H, Karl A, Rana M, Forrester M, Pomeranz V, Lombi F, et al.
Case Rep Nephrol Urol
. 2013 Oct;
3(1):51-7.
PMID: 24167512
Focal and segmental glomerulosclerosis is classified as either primary or secondary. We present a patient with a past history of biopsy-proven focal and segmental glomerulosclerosis. Despite initial response to dual...
10.
Olson J, Forrester M, Clohessy P, Golden B, Herriot R, Forrester J
Ocul Immunol Inflamm
. 2012 Jul;
4(2):91-8.
PMID: 22827413
Calprotectin, the L1 leucocyte protein, is found in large quantities in the cytosol of granulocytes and monocytes. Plasma calprotectin levels are increased in infections, malignant tumours, vascular insults and various...